Breast-conserving surgery with immediate partial breast reconstruction by using pedicled thoracodorsal artery perforator flap: a 7-year follow-up of 50 women

医学 胸背动脉 乳房再造术 外科 普通外科 乳腺癌 自由襟翼 内科学 癌症
作者
Xing Wang,Ling Huo,Yingjian He,Jinfeng Li,Tianfeng Wang,Zhaoqing Fan,Tao Ouyang
出处
期刊:Breast Care [S. Karger AG]
卷期号:: 1-9
标识
DOI:10.1159/000541340
摘要

Introduction: Thoracodorsal artery perforator (TDAP) flap has been used for more than 10 years in the immediate partial breast reconstruction (IPBR) of breast cancer, allowing many patients to maximize reserved autologous breast tissue who do not have indications for breast-conserving surgery (BCS). No large sample size survival data for this operation have been reported worldwide. Methods: There are 212 primary breast cancer patients who were prepared to receive BCS with IPBR of pedicled TDAP flaps in our institution from June 2013 to December 2017. Finally, the operations were completed successfully in 50 cases. All patients were female with a median age of 40 years. Results: The average diameter of TDAPs measured by Doppler ultrasound before the operation was 1.8 ± 0.6 mm (ranging from 0.6 to 3.3 mm). The average size of the flaps was 15 × 6 cm. The average time of operations was 282 ± 71 min (ranging from 120 to 425 min). The drainage tube was removed 4.8 ± 1.9 days after the operation (ranging from 3 to 12 days). All TDAP flaps survived, and the wound complication rate was 4% (2/50). The median follow-up time was 88 (67, 94) months (M [IQR]), with a 5-year ipsilateral breast tumor recurrence rate of 4% (95% CI: 0.1–9.5%), a 5-year breast cancer-free interval of 88.0% (95% CI: 79.0–97.0%), and a 5-year overall survival rate of 96.0% (95% CI: 90.5–99.9%). Conclusion: IPBR using pedicled TDAP flaps is a good choice for repairing local breast defects in BCS. The advantages of this surgery are no influence on latissimus dorsi function, few complications in the donor area, and good long-term prognosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Hello paper完成签到,获得积分10
2秒前
篇篇高分完成签到,获得积分10
2秒前
邓代容完成签到 ,获得积分10
3秒前
ruxinw发布了新的文献求助10
3秒前
于智豪发布了新的文献求助10
4秒前
5秒前
英姑应助Koi采纳,获得10
5秒前
搜集达人应助yh123采纳,获得10
5秒前
OeO完成签到 ,获得积分10
7秒前
功成完成签到,获得积分10
7秒前
HEIKU应助小鹿采纳,获得10
7秒前
陈一给陈一的求助进行了留言
7秒前
百十余完成签到,获得积分10
8秒前
今后应助金国小王爷采纳,获得10
9秒前
sun发布了新的文献求助50
9秒前
10秒前
Rainbow完成签到 ,获得积分10
10秒前
cm发布了新的文献求助10
12秒前
深情夏彤完成签到,获得积分10
14秒前
16秒前
zqr完成签到,获得积分10
16秒前
阿盛完成签到,获得积分10
18秒前
19秒前
yuying完成签到 ,获得积分10
20秒前
丘比特应助科研通管家采纳,获得10
20秒前
SYLH应助科研通管家采纳,获得30
20秒前
顾矜应助科研通管家采纳,获得10
20秒前
小二郎应助科研通管家采纳,获得10
20秒前
所所应助科研通管家采纳,获得10
20秒前
Lucas应助科研通管家采纳,获得10
20秒前
小小应助科研通管家采纳,获得10
20秒前
JamesPei应助科研通管家采纳,获得10
20秒前
猪猪hero应助科研通管家采纳,获得10
20秒前
赘婿应助科研通管家采纳,获得10
20秒前
Ava应助科研通管家采纳,获得10
20秒前
Jasper应助科研通管家采纳,获得10
20秒前
wanghao完成签到 ,获得积分10
20秒前
完美世界应助科研通管家采纳,获得10
21秒前
21秒前
zic123应助科研通管家采纳,获得20
21秒前
高分求助中
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
Mantodea of the World: Species Catalog Andrew M 500
海南省蛇咬伤流行病学特征与预后影响因素分析 500
Neuromuscular and Electrodiagnostic Medicine Board Review 500
ランス多機能化技術による溶鋼脱ガス処理の高効率化の研究 500
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3464156
求助须知:如何正确求助?哪些是违规求助? 3057470
关于积分的说明 9057304
捐赠科研通 2747508
什么是DOI,文献DOI怎么找? 1507390
科研通“疑难数据库(出版商)”最低求助积分说明 696514
邀请新用户注册赠送积分活动 696062